Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real Life, Non-interventional, Multicentre Study to Assess Resource Utilization and Quality of Life of Patients With Relapsing Forms of Multiple Sclerosis Treated With Dimethyl Fumarate in Greece - the FIDELITY Study

NCT03101735 is registered in ClinicalTrials.gov with Genesis Pharma CNS & Specialty as lead sponsor.

NCT NCT03101735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03101735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real Life, Non-interventional, Multicentre Study to Assess Resource Utilization and Quality of Life of Patients With Relapsing Forms of Multiple Sclerosis Treated With Dimethyl Fumarate in Greece - the FIDELITY Study
Lead sponsor
Genesis Pharma CNS & Specialty
Phase
Observational
Overall status
Completed
Start date
September 23, 2016
Completion date
April 23, 2020
Enrollment
455 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rrms